Steven Cohen’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
Other funds holding LCTX
Steven Cohen's LCTX Position: Q3 2026 in Review
Steven Cohen opened a new position in Lineage Cell Therapeutics (LCTX) in Q3 2026: 29,128 shares worth $27.8K. The stake represents ﹤0.01% of the portfolio and ranks #3792 among its holdings. This is a return to the name: Steven Cohen previously reported a position in LCTX as recently as Q1 2026.
Steven Cohen first reported a position in LCTX in Q1 2023 and has held it in 4 quarters since. The position peaked at $481K in Q1 2026. 143 funds tracked by Wall St. Rank hold LCTX as of Q3 2026.
- Steven Cohen held 29,128 shares of Lineage Cell Therapeutics worth $27.8K as of Q3 2026.
- Lineage Cell Therapeutics was a new Steven Cohen position in Q3 2026.
- Lineage Cell Therapeutics made up ﹤0.01% of Steven Cohen's portfolio in Q3 2026, its #3792 holding.
- Steven Cohen first reported a position in Lineage Cell Therapeutics in Q1 2023 and has held it in 4 quarters since.
- Steven Cohen's Lineage Cell Therapeutics position peaked at $481K in Q1 2026.
- 143 funds tracked by Wall St. Rank held Lineage Cell Therapeutics as of Q3 2026.
Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.